Financials

  • Market Capitalization 208.49 M
  • Employee 95
  • Founded N/A
  • CEO Daniel Vitt
  • Website www.imux.com
  • Headquarter Delaware, United States
  • FIGI BBG001M75SX4
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-4.34
ratio cours/chiffre d'affaires

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
3580
CHRS
Coherus Oncology, Inc. - Common Stock
1.36 USD+0.74%-2.16%-4.23%-15.53%210.12 M USD
3581
DTIL
Precision BioSciences, Inc. - Common Stock
7.61 USD-0.39%-11.72%+6.43%+57.56%210.05 M USD
3589
ANTX
AN2 Therapeutics, Inc. - Common Stock
5.50 USD-0.90%-2.65%+2.04%+391.07%207.55 M USD
3591
BCYC
Bicycle Therapeutics plc - American Depositary Shares
4.10 USD-0.73%-7.24%+7.61%-43.60%207.28 M USD

Nouvelles